Tien Liang BioTech Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Tien Liang BioTech has a total shareholder equity of NT$474.2M and total debt of NT$105.0M, which brings its debt-to-equity ratio to 22.1%. Its total assets and total liabilities are NT$652.4M and NT$178.2M respectively. Tien Liang BioTech's EBIT is NT$10.1M making its interest coverage ratio 10.2. It has cash and short-term investments of NT$189.4M.
Belangrijke informatie
22.1%
Verhouding schuld/eigen vermogen
NT$105.00m
Schuld
| Rente dekkingsratio | 10.2x |
| Contant | NT$189.45m |
| Aandelen | NT$474.18m |
| Totaal verplichtingen | NT$178.21m |
| Totaal activa | NT$652.39m |
Recente financiële gezondheidsupdates
Analyse van de financiële positie
Kortlopende schulden: 4127's short term assets (NT$312.0M) exceed its short term liabilities (NT$144.1M).
Langlopende schulden: 4127's short term assets (NT$312.0M) exceed its long term liabilities (NT$34.1M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 4127 has more cash than its total debt.
Schuld verminderen: 4127's debt to equity ratio has reduced from 32.2% to 22.1% over the past 5 years.
Schuldendekking: 4127's debt is well covered by operating cash flow (58.7%).
Rentedekking: 4127's interest payments on its debt are well covered by EBIT (10.2x coverage).